Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 3 institutions in 2 countries.
Jorge Fernández-VázquezDepartment of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona, 08028 Barcelona, Spain.
Juan David Cabrer-PanesDepartment of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona, 08028 Barcelona, Spain.
Anna ÅbergDepartment of Medical Biochemistry and Biophysics, Umeå University, SE-90187 Umeå, Sweden.
Antonio JuárezDepartment of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona, 08028 Barcelona, Spain.
Cristina MadridDepartment of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona, 08028 Barcelona, Spain.ORCID 0000-0002-5861-3980
Tania Gaviria-CantinDepartment of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona, 08028 Barcelona, Spain.ORCID 0000-0001-7837-3390
Llorenç Fernández-CollDepartment of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona, 08028 Barcelona, Spain.ORCID 0000-0001-8564-8567
Andrés Felipe Vargas-SinisterraDepartment of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona, 08028 Barcelona, Spain.ORCID 0000-0001-6796-8655
Carlos Jonay JiménezDepartment of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona, 08028 Barcelona, Spain.ORCID 0000-0003-2302-4542
Carlos BalsalobreDepartment of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona, 08028 Barcelona, Spain.ORCID 0000-0002-4147-219X
Universitat de Barcelona · ESInstitute for Bioengineering of Catalonia · ESUmeå University · SE
Funding
Government of Catalonia 2017SGR499Ministry of Economy, Industry and Competitiveness AGL2013-45339RSpanish ministry of Science, Innovation and Universities PGC2018-096958-B-I00
6 · The paper itself
Abstract
ppGpp is an intracellular sensor that, in response to different types of stress, coordinates the rearrangement of the gene expression pattern of bacteria to promote adaptation and survival to new environmental conditions. First described to modulate metabolic adaptive responses, ppGpp modulates the expression of genes belonging to very diverse functional categories. In
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
ppGpp, the General Stress Response Alarmone, Is Required for the Expression of the α-Hemolysin Toxin in the Uropathogenic · full record | OpenQuestion